| pubmed-article:19174787 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19174787 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:19174787 | lifeskim:mentions | umls-concept:C0021390 | lld:lifeskim |
| pubmed-article:19174787 | lifeskim:mentions | umls-concept:C0031437 | lld:lifeskim |
| pubmed-article:19174787 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:19174787 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:19174787 | lifeskim:mentions | umls-concept:C0750729 | lld:lifeskim |
| pubmed-article:19174787 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19174787 | pubmed:dateCreated | 2009-2-4 | lld:pubmed |
| pubmed-article:19174787 | pubmed:abstractText | Disease course in inflammatory bowel disease (IBD) is variable and difficult to predict. To optimize prognosis, it is of interest to identify phenotypic characteristics at disease onset and other prognostic factors that predict disease course. The aim of this study was to evaluate such factors in a population-based IBD group. | lld:pubmed |
| pubmed-article:19174787 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19174787 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19174787 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19174787 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19174787 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19174787 | pubmed:issn | 1572-0241 | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:DagnelieP CPC | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:StockbrüggerR... | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:WoltersF LFL | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:KesterA D MAD | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:RusselM G V... | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:EngelsL G J... | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:Romberg-Camps... | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:Hesselink-van... | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:CilissenMM | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:Van DeursenCC | lld:pubmed |
| pubmed-article:19174787 | pubmed:author | pubmed-author:HameetemanW... | lld:pubmed |
| pubmed-article:19174787 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19174787 | pubmed:volume | 104 | lld:pubmed |
| pubmed-article:19174787 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19174787 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19174787 | pubmed:pagination | 371-83 | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:meshHeading | pubmed-meshheading:19174787... | lld:pubmed |
| pubmed-article:19174787 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19174787 | pubmed:articleTitle | Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. | lld:pubmed |
| pubmed-article:19174787 | pubmed:affiliation | Department of Gastroenterology and Hepatology, Maastricht University Medical Center, University of Maastricht, The Netherlands. m.camps@orbisconcern.nl | lld:pubmed |
| pubmed-article:19174787 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19174787 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174787 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174787 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174787 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174787 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174787 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19174787 | lld:pubmed |
